GlobeImmune Inc.

(GBIM)

By |

Profile

GlobeImmune Inc is a US-based biopharmaceutical company which focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen platform. It develops few Tarmogen product candidates for infectious disease and multiple cancer indications. The pipeline products of the company are GS-4774, GI-19000, GI-2010, GI-18000 which targets HBV and HIV antigens, TB antigens and Delta virus antigens and Oncology product candidates such as GI-6207, GI-6301, GI4000 which targets Carcinoembryonic antigen, Brachyury, and Mutated Ras.

Contact Information

Website: www.globeimmune.com
Main Phone: +1 303 625-2700
Address: 1450 Infinite Drive
State: CO
City / Town: Louisville
Country: USA
Postal Code: 80027

Issuer Information

Exchange: OTO
CEO: Timothy C. Rodell
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.21 $ 0.018 (9.42%)
Last Price 0.21 Change $ 0.018 Change % 9.42 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.21 High 0.21 Low 0.21 Prev Close 0.19
Last Trade Volume 100 52 Wk Hi 0.70 52 Wk Low 0.16
Market Cap 1.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,751,574.00 EPS (TTM) -0.39 PE Ratio N/A Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
S. Edward Torres 1,000
Timothy C. Rodell 1,000
Daniel J. Mitchell 1,000
Daniel J. Mitchell 1,000
Last 10 Sell Shares
Augustine J. Lawlor 1,000
Daniel J. Mitchell 1,000
Daniel J. Mitchell 1,000
S. Edward Torres 1,000
Daniel J. Mitchell 1,000
Daniel J. Mitchell 1,000
Daniel J. Mitchell 1,000
Daniel J. Mitchell 1,000
Augustine J. Lawlor 1,000
Augustine J. Lawlor 1,000